Category: Heart and Circulation

  • Statins Proven To Cause Increased Injuries

    Part VI of a multi-installment series on cholesterol and the dangers of statin drugs.

    Part V can be found here: Saturated Fats Are NOT Bad For You – Here’s PROOF
    Part IV can be found here: Cholesterol: Life-Giving Or Life-Threatening?
    Part III can be found here: New Research Into Statin Drug Memory Loss
    Part II can be found here: Trade Your High Cholesterol For Diabetes!
    Part I can be found here: Lower Your Cholesterol – Lose Your Marbles?

    By Nurse Mark

     

    StatinWarning The news for statins just keeps getting worse and worse. First it was rhabdomyelosis, a condition that causes muscles to break down – literally melt –  and can lead to kidney damage. Then there is liver damage, sometimes severe enough to require liver transplant, and memory loss and confusion, and type II diabetes…

    Now researchers have found that compared to those people not using statin drugs, statin users were 19 percent more likely to have musculoskeletal problems of all kinds, and 13 percent more likely to suffer from dislocations, strains or sprains.

    What’s even more alarming is that the researcher indicates that people who are physically active are especially at risk!

    And this was not a rat study or small, limited study – no, this study compared nearly 7000 non-statin users with the same number of statin users. In an article published Published online June 3, 2013 in the Journal of the American Medical Association, Dr. Ishak Mansi describes his study of nearly 14,000 U.S. active-duty soldiers and veterans, and confirmed an association between the use of statins and musculoskeletal injuries.

    Conclusions and Relevance:  Musculoskeletal conditions, arthropathies, injuries, and pain are more common among statin users than among similar nonusers. The full spectrum of statins’ musculoskeletal adverse events may not be fully explored, and further studies are warranted, especially in physically active individuals.

     

    Predictably the American heart association is quick to say “Don’t even think of not taking statins…”

    In an article in the government’s National Institutes of Health MedlinePlus news website that discussed this study, Dr. Gregg Fonarow, a spokesman for the American Heart Association, did his best to put a positive spin on the findings saying that statin users should be “reassured” by the findings.

    “This study provides further evidence that the proven cardiovascular benefits outweigh any potential risks, including musculoskeletal issues,”

     

    So, according to Dr. Fonarow, it’s “don’t worry, be happy” when it comes to the damaging side effects of statins.

    Interestingly, Dr. Fonarow has received funding from Pfizer, Merck, Schering Plough, Bristol-Myers Squibb, and Sanofi-Aventis – all of whom depend heavily on the continued sales of statin drugs to maintain their obscene profits… Do you think there could there be even the tiniest hint of a conflict of interest there? No, I didn’t think so either…

    Yep, I’m reassured all right – reassured that I never, ever want to take this dangerous, damaging drug!

    Muscle damage, kidney damage, liver damage, memory loss and confusion, type II diabetes, and increased risk for musculo-skeletal injuries – all that in exchange for depleting your body of cholesterol, a substance essential for health and life?

    There are better options!

    Further Reading:

    Lower Your Cholesterol – Lose Your Marbles?

    Trade Your High Cholesterol For Diabetes!

    New Research Into Statin Drug Memory Loss

    Cholesterol: Life-Giving Or Life-Threatening?

    Saturated Fats Are NOT Bad For You – Here’s PROOF

     

    References:

    JAMA study publication: Statins and Musculoskeletal Conditions, Arthropathies, and Injuries
    JAMA Intern Med. 2013
    http://archinte.jamanetwork.com/article.aspx?articleid=1691918

    MedlinePlus article:
    Cholesterol Drugs Linked to Muscle, Joint Problems: Study
    But heart benefits of statins outweigh risks, expert says
    Monday, June 3, 2013
    http://www.nlm.nih.gov/medlineplus/news/fullstory_137444.html

    Dr Fonarow financial ties: http://www.medscape.com/viewarticle/737248

  • Saturated Fats Are NOT Bad For You – Here’s PROOF

    Part V of a multi-installment series on cholesterol and the dangers of statin drugs.

    Part IV can be found here: Cholesterol: Life-Giving Or Life-Threatening?
    Part III can be found here: New Research Into Statin Drug Memory Loss
    Part II can be found here: Trade Your High Cholesterol For Diabetes!
    Part I can be found here: Lower Your Cholesterol – Lose Your Marbles?

    By Nurse Mark

     

    StatinWarning After decades of being told that saturated fats in our diet is what has caused untold misery and suffering for mankind in the form of heart disease, the truth is beginning to come out. Every day new voices join a growing chorus that are shouting “the emperor has no clothes” as they present their research showing that saturated fats like animal fats, eggs, cheese, butter, coconut and palm oils, fish oils, and others are not the “instant heart-attack” that we’ve been warned about – that indeed, our obsession with “low fat” and conventional medicine’s war on fats is actually harming us.

    Dr Glen D Lawrence of Long Island University in Brooklyn, NY is the most recent of these scientists brave enough to speak out against the fat-is-bad party line.

    In a study published May 1, 2013 in the journal Advances in Nutrition Lawrence concludes:

    “The influence of dietary fats on serum cholesterol has been overstated, and a physiological mechanism for saturated fats causing heart disease is still missing.”

     

    He goes on to say:

    Various aldehydes produced in the oxidation of PUFAs, as well as sugars, are known to initiate or augment several diseases, such as cancer, inflammation, asthma, type 2 diabetes, atherosclerosis, and endothelial dysfunction. Saturated fats per se may not be responsible for many of the adverse health effects with which they have been associated; instead, oxidation of PUFAs in those foods may be the cause of any associations that have been found. Consequently, the dietary recommendations to restrict saturated fats in the diet should be revised to reflect differences in handling before consumption, e.g., dairy fats are generally not heated to high temperatures. It is time to reevaluate the dietary recommendations that focus on lowering serum cholesterol and to use a more holistic approach to dietary policy.

     

    So, there we have it – saturated fats are not “the great Satan” that the religion of no fat preaches about.

    Lawrence’s contention that oxidized PUFAs (Poly Unsaturated Fatty Acids – like vegetable oils) agrees with our experience – these oils such as flax oil and olive oil are not necessarily bad, but they are easily damaged and oxidized turning them rancid. They should never be used to cook with as they do not tolerate heat.

    What we need to be restricting is our exposure to trans fats, PUFAs, sugars, and starches. These are the things that are responsible for the explosion of cardiovascular disease, obesity, metabolic syndrome, and diabetes in our modern world.

    Ditch the “low-fat” foods, the margarine, and that “heart-healthy” corn oil; enjoy your steak, butter, bacon, and eggs.

    Your heart will thank you!

    Reference:

    Dietary Fats and Health: Dietary Recommendations in the Context of Scientific Evidence
    Glen D. Lawrence, Department of Chemistry and Biochemistry, Long Island University, Brooklyn, NY
    Adv Nutr May 2013 Adv Nutr vol. 4: 294-302, 2013
    http://advances.nutrition.org/content/4/3/294.long#abstract-1

  • Cholesterol: Life-Giving Or Life-Threatening?

    Part IV of a multi-installment series on cholesterol and the dangers of statin drugs.

    Part III can be found here: New Research Into Statin Drug Memory Loss
    Part II can be found here: Trade Your High Cholesterol For Diabetes!
    Part I can be found here: Lower Your Cholesterol – Lose Your Marbles?

    By Nurse Mark

     

    In recent HealthBeat articles I’ve been talking a lot about statin drugs and their dangers.

    Conventional medicine tells us we must take statin drugs to lower our cholesterol levels and thus prevent heart attacks.

    Is that true? If someone has a high cholesterol level will they have a heart attack just as surely as night follows day? Is lower always better when it comes to cholesterol levels?

    Hearing Big Pharma talk you could easily believe that cholesterol is a toxic substance that must be eliminated from our bodies by any means.

    We think a little differently here. Let’s learn a little more about cholesterol.

    What is this stuff, anyway?

    Cholesterol is a fatty, waxy substance, an organic molecule – a sterol – that is an essential part of the structure of almost all the cells in our body.

    Where does it come from?

    Cholesterol can be obtained from diet from animal sources like meat and dairy – though plant sources may contribute small amounts of cholesterol-like substances called phytosterols. It is also made in substantial amounts by the liver. It is so important that even the cells themselves are able to make cholesterol – usually in response to high insulin levels.

    What good is it?

    Cholesterol helps make the outer coating or wall of cells, keeping them “waterproof” and controlling what can enter and exit the cell. It is used to make the bile acids that digest food (especially fatty foods) in the intestine. It is used by the body to make Vitamin D and steroid hormones such as estrogen in women and testosterone in men. Cholesterol also forms the “insulation” that protects our nerves ability to transmit impulses and is used as a material to repair irritations and damage in our blood vessels.

    How much of it do we need?

    According to Harvard University researchers, we require about 1000 mg (one gram) of cholesterol each day for our body to function properly. We could eat no cholesterol at all and our liver would still make that much or more.

    Is it really that simple? Isn’t there “good” and “bad” cholesterol?

    You’re right, it’s not so simple. There are several different forms of cholesterol, each doing different jobs in our body.

    The good, the bad, and the ugly?

    Kind of: here is the brief rundown on the different forms of cholesterol:

    First, cholesterol itself really isn’t very soluble in blood (think of oil in water) so our body wraps it up into molecules called lipoproteins so it can be moved around through our arteries and veins.

    The good: HDL (High Density Lipoprotein) cholesterol is considered “good” because it gathers up unneeded cholesterol from the blood vessels and cells and transports it back to the liver for recycling or excretion as bile. HDL is also felt to have an anti-inflammatory role in the body.

    The bad: LDL (Low Density Lipoprotein) cholesterol carries cholesterol to the areas of the body where it is needed. It has been thought to be “bad” because high levels of LDL in the blood have been associated with increased risk of cardiovascular disease. However, “associated with” is not the same as “causes” and we like to refer to cholesterol as it relates to heart disease as “found at the scene of the crime, but NOT GUILTY!

    To make things more confusing, there are two sub-types of LDL: Small, dense LDL is also considered to be a form of “bad” cholesterol while large, buoyant LDL is less harmful. (There is also a form of HDL that is considered “bad

    The ugly: Oxidized LDL cholesterol particles are strongly associated with atheroma formation in the walls of arteries, a condition known as atherosclerosis which is the principal cause of coronary heart disease and other forms of cardiovascular disease. Oxidized LDL particles contain free radicals and are irritating and damaging to the cell walls, causing inflammation and even endothelial (the cells that line the blood vessels) death. Our body then tries to repair the damage by patching it with LDL cholesterol deposits – like a protective “scab” inside the blood vessel. (Remember – LDL is “found at the scene of the crime, but NOT GUILTY!”) Oxidized LDL is also said to increase the production of a substance called thromboxane in blood platelets – which promotes blood clotting.

    How does the “Ugly” happen?

    A number of things have been shown to cause LDL to become “oxidized” – some of them include:

    Smoking – is this any surprise? Smoking also inhibits our ability to make prostacyclin, a substance that inhibits blood clotting. By increasing the ratio of thromboxane to prostacyclin, abnormal clotting can occur, causing cardiovascular events and sudden death.

    Trans fats and polyunsaturated fats. For years conventional medicine has tried to blame saturated fats like butter for heart disease, telling us to eat margarine and vegetable oils instead. That is beginning to change, with conventional researchers Now beginning to acknowledge that saturated fats are healthy , polyunsaturated fats are easily damaged and can quickly become unhealthy, and trans fats are very disruptive and damaging and should be avoided at all costs.

    Metabolic Syndrome, pre-diabetes, obesity and diabetes have all been linked to increases in oxidized LDL, and correcting those conditions appears to reduce oxidized LDL.

    Deficiencies in vitamin E, carotenoids, and vitamin C – all potent antioxidants – are also associated with the oxidation of LDL.

    And the odd man out:

    Triglycerides are fat-like substances that circulate in the blood. Conventional medicine associates high triglyceride levels with heart disease in the same way they do LDL cholesterol – and they claim that there is great benefit in dramatically lowering triglyceride levels. However, while high triglyceride levels are related to an increased risk of heart disease, they are also correlated with low HDL (good) cholesterol, and with small, dense (less bad)  LDL, so it’s not clear whether high triglycerides are really an independent risk factor for heart disease or just a risk marker for heart disease – as in “found at the scene of the crime, but not guilty!” 

    What to do about cholesterol?

    First, don’t let conventional medicine and Big Pharma frighten you about cholesterol – it really is our friend, and essential to life. Cholesterol is essential for so many functions – our thoughts, emotions, and mental functions, our digestion, our hormones and everything that they control for us, for repairing our wounds, and even protecting us from infection.

    Current conventional medical guidelines claim that total cholesterol should be below 200 mg/dL, LDL below 100 mg/dL, triglycerides below 150 mg/dL, and HDL above 40 mg/dL for men and 50 mg/dL for women.

    Please remember though that these recommendations are used to sell patients on the need to take statin drugs, and Big Pharma is constantly pushing for ever-lower total cholesterol, LDL, and triglyceride numbers in order to sell more of their drugs.

    Next, be aware that there is very little real proof that artificially lowering total cholesterol, LDL, or triglycerides does anyone much good, and there is evidence that for many, higher cholesterol levels can actually be protective. There is statistical data showing that low cholesterol levels in seniors are associated with an increase in all-cause mortality.

    Finally, it is not the raw numbers themselves that should be used to determine whether one’s cholesterol is “too high” – it is the relationship of those numbers to the other numbers – that is, the ratio of LDL to HDL and even the more detailed measurement of “large” and “small” particle LDL – that should be looked at.

    On Lowering cholesterol:

    Statins, of course, are the first and often the only choice of conventional doctors when they find cholesterol and triglyceride numbers above the conventionally accepted range. Some silly diet advice, such as “avoid eggs and fatty foods” may also be given.

    Both of those recommendations, are just plain wrong. Statin drugs come with a wide variety of very worrisome side effects such as loss of memory and metal function, muscle damage, diabetes, and liver failure. Avoiding dietary cholesterol, as we have seen, is futile – our liver will just take up the slack to make this important substance, and the foods that are “substituted” for healthy cholesterol-containing foods often contain high amounts of trans fats or high fructose corn syrup and other sugars – which all contribute to the creation of the artery-damaging oxidized LDL that we learned about earlier.

    Since we believe that cholesterol is actually a good and necessary thing, we feel that instead of simply trying to slam down the numbers with a drug a more sensible approach is to shift that important LDL/HDL ration toward more of the protective HDL and to avoid creating the blood vessel damaging oxidized LDL.

    How to shift the balance toward better cholesterol and cardiovascular health

    Hint: Lifestyle and diet are amazingly effective!

    Here are some things you can do (not in any order of importance – they are all important!)

    • Moderate alcohol – one or two drinks per day – has been shown to raise HDL cholesterol – but too much can significantly raise triglyceride levels.
    • Do you smoke? Stop! Stopping smoking lowers LDL and raises HDL cholesterol.
    • Are you overweight? Losing weight raises HDL cholesterol.
    • Get some sun – researchers have shown that exposure to ultraviolet radiation (sunlight) results in a significant and long-lasting reduction in cholesterol levels.
    • Relax – stress reduction, meditation and yoga have been shown to reduce total and LDL cholesterol and triglycerides.
    • Get moving – aerobic exercise (walking, jogging, swimming, bicycling, rowing, stair-climbing, etc) improves the ratio of LDL to HDL significantly.
    • Eat fats wisely – avoid trans fats. A diet low in trans fats lowers overall cholesterol and raises HDL.
    • Avoid sugars and high glycemic index carbohydrates (potatoes, rice, bread, corn, etc.) – a diet high in sucrose has been shown to decrease HDL – the “good” cholesterol.
    • Get more fiber – a minimum of 2-10 grams/day of soluble fiber lowers cholesterol levels very significantly.

     

    Getting the Big Picture:

    Instead of focusing on one very small aspect of cardiovascular health, cholesterol, and trying to chase laboratory numbers with drugs, Dr. Myatt recommends that people look at the overall picture of their heart health risk factors and she has researched and prepared a Medical White Paper that discusses these risk factors in detail. She is making this paper available to you free of charge. I hope you will take advantage of this offer and download and study this document. Print it and discuss it with your doctor. Use it to reduce your risk factors so that you can enjoy a long and healthy life – and continue to be a HealthBeat News subscriber!

    Please visit this webpage at The Wellness Club to obtain your copy of Dr. Myatt’s Cardiovascular Checklist.

    Please print this Medical White Paper, including the pages of references, so that you can show it to your doctor / cardiologist. When he / she tells you that 1) he has never heard of some of these tests, 2) you don’t need them, 3) he’s not going to order them for you, and 4) your insurance won’t pay for them anyway, please visit Dr. Myatt’s Wellness Club where Dr. Myatt will make these tests available to you, and at a very reasonable cost.

    Dr. Myatt’s Cardiovascular Risk Profile Lab Testing information.

    Dr. Myatt will also be following up this article with one of her own detailing her favorite natural supplements and remedies to improve your cholesterol ratios and cardiovascular health – so stay tuned!

     

    References and additional reading:

    CHOLESTEROL (and other cardiovascular risk markers) http://www.acsu.buffalo.edu/~shlevy/choles.htm

    Excerpted from The Harvard Medical School Guide to Lowering Your Cholesterol
    By Mason W. Freeman, M.D. with Christine Junge
    http://www.health.harvard.edu/newsweek/Understanding_Cholesterol.htm

    The Cholesterol Myths by Uffe Ravnskov, M.D., Ph.D.
    Your cholesterol tells very little about your future health – An excerpt from my previous book The Cholesterol Myths (out of print). http://www.ravnskov.nu/myth1.htm

    Weston A Price Foundation
    Myths & Truths About Cholesterol
    http://www.westonaprice.org/cardiovascular-disease/myths-a-truths-about-cholesterol

    Weston A Price Foundation
    Cholesterol: Friend Or Foe?
    http://www.westonaprice.org/know-your-fats/cholesterol-friend-or-foe

    Oxysterols and TBARS are among the LDL oxidation products which enhance thromboxane A2 synthesis by platelets
    MohamedainM Mahfouza, FredA Kummerowa, ,
    University of Illinois, Burnsides Research Laboratory, 1208 W. Pennsylvania Ave., Urbana, IL 61801 and The H.E. Moore Heart Research Foundation, Champaign, IL 61820, USA
    http://www.sciencedirect.com/science/article/pii/S0090698098000562

    Medscape News
    Dietary Saturated Fat Has Undeserved Bad Reputation, Says Review
    Steve Stiles, May 17, 2013
    “The influence of dietary fats on serum cholesterol has been overstated,” concludes a review in an American Society for Nutrition publication that, in its words, “calls for a rational reevaluation of existing dietary recommendations that focus on minimizing dietary SFAs [saturated fatty acids], for which mechanisms for adverse health effects are lacking”
    http://www.medscape.com/viewarticle/804400?src=wnl_edit_specol

    Triglycerides and Risk for Coronary Heart Disease
    Patrick E. McBride, MD, MPH
    JAMA. 2007;298(3):336-338. doi:10.1001/jama.298.3.336.
    “…a high serum triglyceride level is associated with abnormal lipoprotein metabolism, as well as with other CHD risk factors including obesity, insulin resistance, diabetes mellitus, and lowered levels of high-density lipoprotein cholesterol (HDL-C). When determining CHD risk, how important is it to know which came first—high serum triglyceride levels or the risk factors that cause high levels?”
    http://jama.jamanetwork.com/article.aspx?articleid=207954

    Rejuvenation Res. 2011 April; 14(2): 111–118.
    Effect of Obesity, Serum Lipoproteins, and Apolipoprotein E Genotypes on Mortality in Hospitalized Elderly Patients
    Filomena Addante, M.D. et. al.
    “In addition, we found that, unlike in nonelderly patients, higher levels of TC in females and LDL-C in males are associated with a lower risk of mortality. This paradoxical result is in line with previous reports showing that hypercholesterolemia is associated with lower mortality in elderly patients. ”
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092981/

    Wesley D, Cox HF. Modeling total cholesterol as predictor of mortality: the low-cholesterol paradox. J Insur Med. 2011;42(2-4):62-75.

    Nago N, Ishikawa S, Goto T, et al. Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School Cohort Study. J Epidemiol. 2011;21(1):67-74.

    Schalk BW, Visser M, Deeg DJ, et al. Lower levels of serum albumin and total cholesterol and future decline in functional performance in older persons: the Longitudinal Aging Study Amsterdam. Age Ageing. 2004 May;33(3):266-72.

    Altschul R. “Ultraviolet irradiation and cholesterol metabolism.” Arch Phys Med 1955; 36: 394

    Effects of dietary sucrose on factors influencing cholesterol gall stone formation
    D WERNER, P M EMMETT, AND K W HEATON
    From the University Department of Medicine, Bristol Royal Infirmary, Bristol
    Hence, the well-documented ability of dietary sucrose to raise plasma triglyceride concentrations, which was confirmed in this study, suggests that dietary sucrose will predispose at least some individuals to gall stones.
    http://gut.bmj.com/content/25/3/269.full.pdf

    Pediatrics. 1995 Nov;96(5 Pt 2):1005-9.
    The role of fiber in the treatment of hypercholesterolemia in children and adolescents.
    Kwiterovich PO Jr.
    Department of Pediatrics, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
    For example, the addition of supplemented soluble fiber (psyllium) to a step 1 diet may provide additional lowering of LDL cholesterol of 10% to 15%.
    http://www.ncbi.nlm.nih.gov/pubmed/7494671

  • Trade Your High Cholesterol For Diabetes!

    Part II of a multi-installment series on cholesterol and the dangers of statin drugs.

    What a Deal! You can drive your cholesterol levels dangerously low while developing Type II Diabetes at the same time! Wow – thanks Big Pharma!

     

    By Nurse Mark

     

    StatinWarning In my last HealthBeat article Lower Your Cholesterol – Lose Your Marbles? I talked about how the mighty FDA – the thuggish bodyguard to Big Pharma – has had to ask it’s corporate masters to include new warnings about dangerous side effects on the information inserts for statin drugs.

    You know the ones, those tightly folded papers covered in tiny print that describe a drug’s side effects in mind-numbingly boring terms. You read them all the time, right? Yeah, I thought so…

    The dangers of these drugs are becoming so obvious that the FDA can’t ignore them any longer – hence the new warnings about memory loss and confusion, Type II diabetes, liver failure, and muscle damage.

    Even so, says the FDA, we mustn’t stop using statins, for their “benefits” far outweigh the “rare” risks of complications like these.

    We’ll talk about the supposed “benefits” of statins in an upcoming article, but for right now let’s look at one of these “rare” risks that the FDA is finally admitting to.

    Folks, I don’t know about you, but any risk of developing Type II diabetes with all the complications that go along with it is too great a risk for me to take willingly. Some of those complications include heart disease. Uh, wait a minute… isn’t that what the statin was supposed to fix?

    And “rare”? It seems to me that with the increase in risk for developing diabetes while taking a statin running as high as 22 percent according to a most recent study this is a risk that is a little more than “rare.”

    Canadian researchers examined the medical records of over a million and a half elderly people in the province of Ontario to examine the association between statin use and new onset diabetes and they reported their findings in the British Medical Journal.

    The results do not look good for statins, and while there will surely be attempts made to discredit the study, the results of the researchers are not new – similar results have been obtained in past studies. The evidence is mounting.

    In a study published in the medical journal The Lancet in 2010 researcher David Preiss, MRCP, a clinical research fellow at the British Heart Foundation Glasgow Cardiovascular Research Center at the University of Glasgow in Scotland reported similar, though less dramatic findings. That study was however very careful to state the opinion that the risk of diabetes was low compared to the risk of heart disease and that patients should not stop taking statins…

    Now, to be fair, some research has shown that some forms of statin drugs may actually protect from the development of diabetes – in previous research, the popular statin Crestor has been associated with up to a 27 percent higher risk of diabetes, while the older and somewhat less popular statin Pravachol was said to be linked to a 30 percent lower risk. While it may be better from the standpoint of causing diabetes, Pravachol still brings all the other worrisome side effects common to the other statin drugs – muscle damage, liver damage, memory loss and confusion. Not my idea of a fun time…

    So, is it worth it? Remember, cholesterol is essential to life – so essential that our liver will make it from new even if we never eat another thing containing cholesterol. Cholesterol is a major component of the walls of our cells – it is our “waterproofing.” It is the substance that keeps the insides in and the outside out. It’s also the basic building block for the hormones that keep our endocrine system going. It’s the substance that forms the insulating sheaths on our nerves, just like the insulation on the wires in your home.

    Is it really worth driving away this essential substance, at the risk of inviting in diabetes?

    Personally I don’t think so – and we’ll talk more about some of the other dangers of statin drugs soon!

     

    Additional reading:

    FDA Consumer Information: FDA Expands Advice on Statin Risks
    http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm293330.htm

    FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs
    http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm

    Dangers of Statin Drugs: What You Haven’t Been Told About Popular Cholesterol-Lowering Medicines          
    Sally Fallon and Mary G. Enig, PhD
    http://www.westonaprice.org/cardiovascular-disease/dangers-of-statin-drugs

    http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61965-6/abstract
    The Lancet, Volume 375, Issue 9716, Pages 735 – 742, 27 February 2010
    Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
    Findings
    We identified 13 statin trials with 91 140 participants, of whom 4278 (2226 assigned statins and 2052 assigned control treatment) developed diabetes during a mean of 4 years. Statin therapy was associated with a 9% increased risk for incident diabetes (odds ratio [OR] 1·09; 95% CI 1·02—1·17), with little heterogeneity (I2=11%) between trials. Meta-regression showed that risk of development of diabetes with statins was highest in trials with older participants, but neither baseline body-mass index nor change in LDL-cholesterol concentrations accounted for residual variation in risk.

    http://www.nlm.nih.gov/medlineplus/news/fullstory_137140.html
    Could Statins Raise Diabetes Risk? Some popular brands associated with high blood sugar levels in study, but odds of problems are low. By Margaret Farley Steele Friday, May 24, 2013 MedLinePlus

    http://www.bmj.com/content/346/bmj.f2610
    Risk of incident diabetes among patients treated with statins: population based study
    BMJ 2013 (Published 23 May 2013)
    Discussion
    In this population based study, we found that patients treated with atorvastatin, rosuvastatin, or simvastatin were at increased risk of new onset diabetes compared with those treated with pravastatin.

  • Lower Your Cholesterol – Lose Your Marbles?

    Part I of a multi-installment series on cholesterol and the dangers of statin drugs.

    By Nurse Mark

     

    It seems so…

    StatinWarning

    The evidence has become so compelling that statin drugs cause memory and cognition (thinking) problems that even the mighty FDA, sworn protector of the pharmaceutical industry, has been forced to require drug makers to mention the possibility of “Memory loss and confusion” as an adverse effect in the fine print of their drug labels.

    Well, whoop-tee-doo!
    Who reads all that fine print stuff anyway?!?

    But, says the FDA “expert”, you mustn’t stop taking those statins because the drug companies say they will keep you from having a heart attack, and besides, these episodes of cloudy thinking, loss of memory, and confusion are “rare.”

    Riiiight… “rare.”

    So rare that the FDA has been forced to ‘fess up and require label warnings…

    And, according to the FDA: “The reports about memory loss, forgetfulness and confusion span all statin products and all age groups. Egan [the FDA “expert”] says these experiences are rare but that those affected often report feeling “fuzzy” or unfocused in their thinking.”

    So fuzzy and unfocussed that some elderly statin users are being mis-diagnosed and treated as having senile dementia or even Alzheimer’s ? Maybe even being prescribed drugs based on such a misdiagnosis? Or worse yet, that someone might become so confused that they find themselves forced out of their home and into a “care facility”?

    I would hate to think that such a tragic mis-diagnosis could happen, but anecdotal reports of this are becoming more common with each passing day. And if the FDA is forcing drug makers to warn users about this it certainly must be more than “just” anecdotal reports – it must be a real thing.

    So, where is the “hard evidence” that statins cause memory or cognition problems? Good Question! In reviewing the medical literature it’s almost impossible to find anything – nary a study, an article, a case review – that is critical of statin drugs. Even those articles that report less-than-favorable effects from statin use do so in the most mild, weasel-worded way possible – as if the authors are terrified of incurring the wrath of Big Pharma for criticizing what has become one of the biggest cash cows in modern history.

    In fact, you can find citations (medical and scientific articles or references) that actually try to make a case for statins improving mental function in elderly people! Digging a little deeper into those articles usually finds that 1.) the evidence for improvement is weak at best and 2.) either the “study” was funded directly by a drug company or the authors of the study had significant ties to and support from Big Pharma. This tends to make my B.S. warning light flash… (B.S. means Bad Science folks!)

    But once away from the “conventional” scientific and medical literature where Big Pharma is in control there are plenty of stories about people becoming confused or losing their memory after starting on statins. There are even carefully researched studies reporting problems that Big Pharma seems all too eager to silence.

    Consider Dr. Duane Graveline – a former NASA astronaut and physician. Graveline experienced first-hand the devastating effects of statin drugs when after taking a relatively low dose of a statin drug for a short while he experienced an episode of total global amnesia, losing his memory for several hours. After he recovered from that episode, regaining his memory, his doctors convinced him that he should try the statin drugs once again, claiming that the memory loss couldn’t possibly be caused by the drugs. He did, and promptly experienced another episode of amnesia.

    Dr. Graveline recovered from that second episode as well and has gone on to research the ill effects of statins, writing books and authoring research papers. For anyone with an interest in the dangers of statins his website – www.SpaceDoc.com – is a “must visit” that offers a wealth of otherwise suppressed information.

    And That’s Not All, Folks!

    In addition to the new warnings about memory loss and confusion that the FDA has been forced to require drug makers to put on their information sheets (the ones that nobody bothers to read anyway…) they have also been forced to admit to some other problems that statins are causing.

    Nothing serious mind you, just little things like Type II diabetes, liver failure, muscle damage

    But don’t worry says the FDA – these problems are “rare.” Never mind that one of the most important muscles in your body and one that’s highly susceptible to statin-induced “damage’ is your heart… or that you only get one liver, or that Type II diabetes is no laughing matter either…

    Those little, “rare” problems are something we’ll talk about in upcoming HealthBeat articles…

     

    Additional reading:

    FDA Consumer Information: FDA Expands Advice on Statin Risks
    http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm293330.htm

    FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs
    http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm

    Dangers of Statin Drugs: What You Haven’t Been Told About Popular Cholesterol-Lowering Medicines           
    Sally Fallon and Mary G. Enig, PhD
    http://www.westonaprice.org/cardiovascular-disease/dangers-of-statin-drugs

    Padala KP, Padala PR, Potter JF.Ann Pharmacother. 2006 Oct;40(10):1880-3. Epub 2006 Aug 29. Simvastatin-induced decline in cognition. http://www.ncbi.nlm.nih.gov/pubmed/16940411
    CASE SUMMARY:
    A 64-year-old man developed cognitive difficulties within one week after starting simvastatin 40 mg/day. There was a 3 point decline from baseline in the Mini-Mental State Exam (MMSE) score 2 weeks after simvastatin was initiated, as well as declines in the Activities of Daily Living and Instrumental Activities of Daily Living scales. Simvastatin was discontinued, and the patient’s cognition improved to baseline within 6 weeks. Rechallenge with simvastatin at half the original dose was attempted. His cognition deteriorated over a 2 week period. Simvastatin was stopped, and the patient’s MMSE scores returned to baseline within 4 weeks.
    CONCLUSIONS:
    Statins are commonly used in the older population. Simvastatin appeared to be associated with worsened cognition in our patient, an older person with preexisting memory problems. Statins should be used with caution in this vulnerable population.

    Orsi A, Sherman O, Woldeselassie Z. Pharmacotherapy. 2001 Jun;21(6):767-9. Simvastatin-associated memory loss. http://www.ncbi.nlm.nih.gov/pubmed/11401190
    Abstract
    The statins are widely used to treat dyslipidemias. They are generally associated with mild adverse effects, but rarely, more serious reactions may occur. A 51-year-old man experienced delayed-onset, progressive memory loss while receiving simvastatin for hypercholesterolemia. His therapy was switched to pravastatin, and memory loss resolved gradually over the next month, with no recurrence of the adverse effect.

    Benito-León J, Louis ED, Vega S, Bermejo-Pareja F. J Alzheimers Dis. 2010;21(1):95-102. doi: 10.3233/JAD-2010-100180.
    Statins and cognitive functioning in the elderly: a population-based study. http://www.ncbi.nlm.nih.gov/pubmed/20413854
    Source
    The Department of Neurology, University Hospital 12 de Octubre, Madrid, Spain.
    In this population-based sample, elderly participants treated with statins and untreated controls performed similarly in all tested cognitive areas. These results do not support a positive benefit of statins on cognition.

    Galatti L, Polimeni G, Salvo F, Romani M, Sessa A, Spina E. Pharmacotherapy. 2006 Aug;26(8):1190-2. Short-term memory loss associated with rosuvastatin. http://www.ncbi.nlm.nih.gov/pubmed/16863497
    Abstract
    Memory loss and cognitive impairment have been reported in the literature in association with several 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins), but we found no published case reports associated with rosuvastatin. To our knowledge, this is the first reported case of rosuvastatin-related short-term memory loss. A 53-year-old Caucasian man with hypercholesterolemia experienced memory loss after being treated with rosuvastatin 10 mg/day. He had no other concomitant conditions or drug therapies. After discontinuation of rosuvastatin, the neuropsychiatric adverse reaction resolved gradually, suggesting a probable drug association. During the following year, the patient remained free from neuropsychiatric disturbances. Clinicians should be aware of possible adverse cognitive reactions during statin therapy, including rosuvastatin.

    http://www.scientificamerican.com/article.cfm?id=its-not-dementia-its-your-heart-medication
    Newsmagazine Scientific American
    It’s Not Dementia, It’s Your Heart Medication: Cholesterol Drugs and Memory
    One day in 1999 Duane Graveline, then a 68-year-old former NASA astronaut, returned home from his morning walk in Merritt Island, Fla., and could not remember where he was. His wife stepped outside, and he greeted her as a stranger. When Graveline’s memory returned some six hours later in the hospital, he racked his brain to figure out what might have caused this terrifying bout of amnesia. Only one thing came to mind: he had recently started taking the statin drug Lipitor.

    http://www.spacedoc.com/662_cases_memory_loss
    Duane Graveline MD MPH, Jay S. Cohen MD. ATORVASTATIN-ASSOCIATED MEMORY LOSS: ANALYSIS OF 662 CASES  OF COGNITIVE DAMAGE REPORTED TO MEDWATCH
    In 2001, King and colleagues described 2 patients who presented with cognitive impairment (2, 3). The first patient was a 67 year old Caucasian woman with hypertension, dyslipidemia, hypothyroidism and diabetes, who presented with changes in behavioral characterized by mood alterations, lack of interest in routine activities, diminished short term memory (demonstrated on mental status examination), and social impairment. Two months prior to this visit, atorvastatin 10 mg/day was increased to 20 mg/day. The patient had been previously controlled on atorvastatin 10 mg/day without experiencing any adverse events for one year. Atorvastatin was discontinued, but no changes were made to her other concurrent medications, which included levothyroxine, hormone replacement therapy, glyburide and metoprolol. After discontinuation of atorvastatin, the patient reported dramatic improvement in mood, memory and motivation. Repeat mental status examination also demonstrated marked improvement in short term memory. AT 6 months post discontinuation, the patient had experienced no additional impairment.

    The second patient (3) was a 68 year old Caucasian woman with hypertension who was being treated long term with lisinopril, estradiol and atenolol. Her initial evaluation revealed uncontrolled hypertension, hyperlipedemia and an intact memory and judgment and insight. As a result, hydroclothiazide and atorvastatin 10 mg/day were added to her current drug regimen. Approximately 9 months after this initial visit, the patient’s daughter reported noticeable memory impairment, cognitive decline and behavioral changes. The patient was forgetting scheduled routine social events and appointments and neglecting her longstanding exercise program. The patient discontinued atorvastatin on her own, and cognitive improvement was reported in 1 week.

    One month after resolution of symptoms, the patient was re challenged with atorvastatin; the cognitive impairment returned three weeks later. Atorvastatin was a again discontinued and 1 month later the patient reported improvement in memory. Mental status examination demonstrated a return to baseline. Simvastatin 20 mg/day was initiated and, 7 weeks the patient and her daughter reported a return of the memory impairment and cognitive decline. Three weeks after discontinuing simvastatin, these symptoms resolved.

    CONCLUSION
    1) The 662 Medwatch cases of atorvastatin-associated cognitive impairment suggests a causal linkage between the drug and the reported events.  Random analysis of the Medwatch reports demonstrated a high frequency of cases that were definite or probable, thereby adding weight to the possibility of a causal connection between atorvastatin and cognitive impairments.
    2) Accepted reporting rates to Medwatch of drug-related adverse events is 2.5 to 5%.  Golomb et al. suggest it may be even lower with statin-associated adverse events.  If 2.5% of atorvastatin-associated cognitive impairments are reported to Medwatch, then our 662 cases become 26,480 from 1997 through 2006.  If 1% of cases are reported to Medwatch, then 66,200 cases of atorvastatin-associated cognitive impairments may have occurred.
    3) Statin impairment of glial cell synthesis of cholesterol is most likely mechanism but others must be considered.
    4) There is reasonable research evidence that 100% of statin users suffer some cognitive deficit that is not evident to them.